| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | diacylglycerol diphosphate phosphatase activity | 1.00e-05 | 3 | 37 | 2 | GO:0000810 | |
| GeneOntologyMolecularFunction | phosphatidate phosphatase activity | 3.00e-04 | 14 | 37 | 2 | GO:0008195 | |
| GeneOntologyMolecularFunction | lipid phosphatase activity | 5.60e-04 | 19 | 37 | 2 | GO:0042577 | |
| Domain | TCEAL1 | 1.44e-04 | 9 | 38 | 2 | IPR010370 | |
| Domain | Znf_C2H2_matrin | 2.63e-04 | 12 | 38 | 2 | IPR000690 | |
| Domain | BEX | 3.61e-04 | 14 | 38 | 2 | PF04538 | |
| Domain | TF_A-like/BEX | 3.61e-04 | 14 | 38 | 2 | IPR021156 | |
| Domain | - | 6.04e-04 | 18 | 38 | 2 | 1.20.144.10 | |
| Domain | ZF_MATRIN | 6.04e-04 | 18 | 38 | 2 | PS50171 | |
| Domain | acidPPc | 6.04e-04 | 18 | 38 | 2 | SM00014 | |
| Domain | P_Acid_Pase_2/haloperoxidase | 7.48e-04 | 20 | 38 | 2 | IPR000326 | |
| Domain | PAP2 | 7.48e-04 | 20 | 38 | 2 | PF01569 | |
| Domain | RRM | 9.60e-04 | 217 | 38 | 4 | SM00360 | |
| Domain | RRM_dom | 1.13e-03 | 227 | 38 | 4 | IPR000504 | |
| Domain | RRM | 1.19e-03 | 230 | 38 | 4 | PS50102 | |
| Domain | - | 1.48e-03 | 244 | 38 | 4 | 3.30.70.330 | |
| Domain | ZnF_U1 | 1.58e-03 | 29 | 38 | 2 | SM00451 | |
| Domain | Znf_U1 | 1.58e-03 | 29 | 38 | 2 | IPR003604 | |
| Domain | Nucleotide-bd_a/b_plait | 1.82e-03 | 258 | 38 | 4 | IPR012677 | |
| Domain | Znf_C2H2-like | 5.06e-03 | 796 | 38 | 6 | IPR015880 | |
| Domain | ZnF_C2H2 | 5.44e-03 | 808 | 38 | 6 | SM00355 | |
| Domain | RRM_1 | 8.62e-03 | 208 | 38 | 3 | PF00076 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 9757574 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 17185824 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 17590538 | ||
| Pubmed | Characterization and chromosome location of the mouse link protein gene (Crtl1). | 6.96e-06 | 4 | 38 | 2 | 10640815 | |
| Pubmed | TIPUH1 encodes a novel KRAB zinc-finger protein highly expressed in human hepatocellular carcinomas. | 1.16e-05 | 5 | 38 | 2 | 16568080 | |
| Pubmed | 3.24e-05 | 8 | 38 | 2 | 9932288 | ||
| Pubmed | 4.38e-05 | 360 | 38 | 5 | 33111431 | ||
| Pubmed | 6.09e-05 | 195 | 38 | 4 | 19454010 | ||
| Pubmed | The transcription factors L-Sox5 and Sox6 are essential for cartilage formation. | 2.18e-04 | 20 | 38 | 2 | 11702786 | |
| Pubmed | 3.16e-04 | 24 | 38 | 2 | 16221301 | ||
| Pubmed | 4.32e-04 | 28 | 38 | 2 | 22178446 | ||
| Pubmed | 4.63e-04 | 29 | 38 | 2 | 7789972 | ||
| Pubmed | 4.96e-04 | 30 | 38 | 2 | 21911092 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 5.47e-04 | 954 | 38 | 6 | 36373674 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 5.71e-04 | 148 | 38 | 3 | 32538781 | |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | 6.27e-04 | 639 | 38 | 5 | 23443559 | |
| Pubmed | 6.29e-04 | 153 | 38 | 3 | 28225217 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 7.92e-04 | 1024 | 38 | 6 | 24711643 | |
| Pubmed | A targeted proteomic analysis of the ubiquitin-like modifier nedd8 and associated proteins. | 7.97e-04 | 38 | 38 | 2 | 18247557 | |
| Pubmed | 7.97e-04 | 38 | 38 | 2 | 28218735 | ||
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 1.01e-03 | 180 | 38 | 3 | 35198878 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 1.02e-03 | 1489 | 38 | 7 | 28611215 | |
| Pubmed | 1.02e-03 | 181 | 38 | 3 | 37372979 | ||
| Pubmed | Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα. | 1.04e-03 | 182 | 38 | 3 | 32239614 | |
| Cytoband | 2p13.1 | 3.68e-04 | 34 | 38 | 2 | 2p13.1 | |
| Cytoband | 16p11.2 | 5.37e-04 | 191 | 38 | 3 | 16p11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p11 | 1.58e-03 | 278 | 38 | 3 | chr16p11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p13 | 6.04e-03 | 140 | 38 | 2 | chr2p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q36 | 7.72e-03 | 159 | 38 | 2 | chr7q36 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq22 | 8.98e-03 | 172 | 38 | 2 | chrXq22 | |
| GeneFamily | Phospholipid phosphatases | 4.49e-05 | 7 | 27 | 2 | 1067 | |
| GeneFamily | Transcription elongation factor A like family | 7.68e-05 | 9 | 27 | 2 | 1216 | |
| GeneFamily | RNA binding motif containing | 3.83e-03 | 213 | 27 | 3 | 725 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 2.09e-02 | 718 | 27 | 4 | 28 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.77e-06 | 138 | 38 | 4 | 611fe0fb284e12678f9c47a0bdbfc367a93c52b3 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic-Basophil|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.60e-06 | 157 | 38 | 4 | 8c42af7aa1f1b6f4fe2f8d00a8b4a800f121e804 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.60e-06 | 157 | 38 | 4 | ee1be3c756b72fceac6b4ccb416dd4bd031a2193 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.60e-06 | 157 | 38 | 4 | 008f938a338f43c3251dcac574f1b4f689926c71 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-chondrocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.54e-05 | 177 | 38 | 4 | 915b848d789051a1c3bc6f6dc86955bb752276ab | |
| ToppCell | metastatic_Brain-Endothelial_cells-Stalk-like_ECs|metastatic_Brain / Location, Cell class and cell subclass | 1.83e-05 | 185 | 38 | 4 | ad52970e88e8947ef256095bd4b40229b912d58a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.87e-05 | 186 | 38 | 4 | fef543f188edb0d1704d9c6ace366a0f8017bf53 | |
| ToppCell | Ionocyte-iono-4|World / Class top | 1.81e-04 | 129 | 38 | 3 | 85ee6e16959cb58a58f5b09edf1f78d9ce6a9441 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.89e-04 | 131 | 38 | 3 | a3a086ce6e69707ca6a042f3b15c130f81909acb | |
| ToppCell | Severe-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.30e-04 | 140 | 38 | 3 | 683ee5e103f0c68cbbec019249404d381dbc39f3 | |
| ToppCell | Mild/Remission-B_naive-1|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.44e-04 | 143 | 38 | 3 | bd3f5fbd4e9e4dc414682db5607494f3ce988deb | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.44e-04 | 143 | 38 | 3 | 990844ca674d30b2924c74b45bed4fdfb8463fa7 | |
| ToppCell | Control-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.10e-04 | 155 | 38 | 3 | 0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-12|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.16e-04 | 156 | 38 | 3 | 7ece590fd8f29382e349dd0e5e016d2926aeb518 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.16e-04 | 156 | 38 | 3 | 60f1ce38e34b582f589db1e0d6139282c1902b2b | |
| ToppCell | Severe-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.34e-04 | 159 | 38 | 3 | 2881b054bbeb479221ee3c38bbd9b0815b123579 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.40e-04 | 160 | 38 | 3 | 7ad065337ac802de52c15ee715f6b78a3eed0cef | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-iNKT/MAIT-T-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.40e-04 | 160 | 38 | 3 | 5c931e859acf67c1c8664941e0e44d195f8ba75b | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.46e-04 | 161 | 38 | 3 | 5cb91ae9674b370a27be0d5852c3816b4434239e | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.72e-04 | 165 | 38 | 3 | fead3f2032f8fa5f7f0159a4434989b3d65debbb | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D231|Adult / Lineage, Cell type, age group and donor | 3.85e-04 | 167 | 38 | 3 | 5af9127bae05768a5164d5708a4ad37edca99324 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3_VIP_CBLN1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.92e-04 | 168 | 38 | 3 | 2ab11cb9e691ac363e81f985e0450cdd721f9d7a | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D122|Adult / Lineage, Cell type, age group and donor | 3.92e-04 | 168 | 38 | 3 | 8c3e1e45b422813bcdfa4273b1167db649a312f5 | |
| ToppCell | Mild/Remission-B_naive-4|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.99e-04 | 169 | 38 | 3 | c3a6179a64589a370108fea809b157839347759c | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-4|TCGA-Liver / Sample_Type by Project: Shred V9 | 3.99e-04 | 169 | 38 | 3 | 0a3ba6b5d6cff9d3d7f56046063cfc3a37ae1156 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-4_VIP_DSEL|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.13e-04 | 171 | 38 | 3 | 2c7d73f1386ddd172839734c68ed3859a90f80f8 | |
| ToppCell | Control-B_naive-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.13e-04 | 171 | 38 | 3 | d18855b24aadea38fd1e4592f945cf15b85e05f1 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3-6_VIP_KCTD13|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.34e-04 | 174 | 38 | 3 | 62f5dc7086e1491fc90f005ccadfa1b772b52fad | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_endothelial_cell_-_unspecif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.34e-04 | 174 | 38 | 3 | 66a3b20ff1ab9f36fb391986444d7dc99d0c03d1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.41e-04 | 175 | 38 | 3 | e78bf0c33a741bb97e987e41ac33da9e623a08ec | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_GRIP2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.41e-04 | 175 | 38 | 3 | 0c648e7f67ffbe3b476a2ca77d246554f8cd1882 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.49e-04 | 176 | 38 | 3 | 0fb6b57c3fffc93c40f4989007af4d522666c5e9 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.49e-04 | 176 | 38 | 3 | ad05dd934f4ac2e656b3455de091f4c8772de6c8 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-04 | 176 | 38 | 3 | 88ca2f83d8301633232735f39b0683efe49d0b86 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-04 | 176 | 38 | 3 | 7292e014b8f697f0c2e9f47c48333de95cb44a69 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-04 | 177 | 38 | 3 | 291231b1520c135e92739e201495fe1935efa927 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.64e-04 | 178 | 38 | 3 | 20d9433332b58270bca6807a6cf633971dbaa2b7 | |
| ToppCell | E17.5-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell_of_alveolus|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.64e-04 | 178 | 38 | 3 | 982205ba117a4c7b7e9b713689a5b69190f0bca9 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-04 | 180 | 38 | 3 | d67d3196e6cc3dcd31023a4dc69310226181d583 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-04 | 180 | 38 | 3 | 573308d43425d9fba20787abdb7f8efefc48efb5 | |
| ToppCell | NS-critical-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.87e-04 | 181 | 38 | 3 | cfc3ed541d93158ce26641ea30b7573d93600a11 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.87e-04 | 181 | 38 | 3 | 35bcdcd2651149692e5b150e887c0f450c81d2d4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-4_VIP_DSEL|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.87e-04 | 181 | 38 | 3 | 70eff83dd85691e977972c660731394d2fcf5cdf | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-2_VIP_PPAPDC1A|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.87e-04 | 181 | 38 | 3 | 42f5a645beeb5a1a746d79ea7fe7fd3786fd35ad | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic-Mesenchymal_Airway/Vascular|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.95e-04 | 182 | 38 | 3 | bb7de0c93d8f59f13c990e425139b9348ca8027e | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic-Mesenchymal_Airway/Vascular-Chondrocyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.95e-04 | 182 | 38 | 3 | 507f095af4dff60f2c2b64d750477154084c3595 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.95e-04 | 182 | 38 | 3 | 3d7a8d2ee2137b098248597058974ef5ae09c19e | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.95e-04 | 182 | 38 | 3 | 88bd17c07bd8443a0ede4e9dc7bc9d1230b42211 | |
| ToppCell | wk_20-22-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.95e-04 | 182 | 38 | 3 | 03a5a02acd48f0eb210485348bfe0cd21f486215 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.95e-04 | 182 | 38 | 3 | 420a8fd30543e37a66ba0786215d056d308660d0 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.95e-04 | 182 | 38 | 3 | ad4d74d8b19976e1ccc3c5ba8013199338cf6fd8 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.19e-04 | 185 | 38 | 3 | f98af3146ec2f44c30d31a662fb9c4fa3ca4f706 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium_(RGS5+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.19e-04 | 185 | 38 | 3 | 11fbea1eb1d9a3e4480d0d2b0f7b02e2866b8142 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.19e-04 | 185 | 38 | 3 | cefd81adb480c027545a5c78dcd05669783717f4 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.19e-04 | 185 | 38 | 3 | bdfa8c284bbc5e85c806327fbb7778cf16242a38 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1_VIP_PCDH20|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.27e-04 | 186 | 38 | 3 | 531774f2ba8bef5ed355edc86c670bb97ae85900 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery|Adult / Lineage, Cell type, age group and donor | 5.27e-04 | 186 | 38 | 3 | 2d1c4ea2e401db89971582ee54618a8b0c81b8ac | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-VSMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.27e-04 | 186 | 38 | 3 | c7885fd6dc7dc8fffc96f0112c51a365cf8a8f80 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.36e-04 | 187 | 38 | 3 | ae2ee6f8e5c37cb88a67f3e742cf86e57657bfaf | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-Pericytes-Pericyte|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.61e-04 | 190 | 38 | 3 | 136ca6da77a202874376af193a1dd71d810c76c4 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.61e-04 | 190 | 38 | 3 | 498bbe063bc75d323cb186a82cce122b511d2cff | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.69e-04 | 191 | 38 | 3 | 764c3a8829ae1253a0790744138266e81fc075ec | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.69e-04 | 191 | 38 | 3 | 98b907f8fa024cf32e462323b782c5a371327bbd | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-OPC_related-OPC|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 5.78e-04 | 192 | 38 | 3 | 5d9bc234f01c73b2531edf8960588d5b6cf260a7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.78e-04 | 192 | 38 | 3 | 3abee376c37c3646da33ac381aa63d50a01607a6 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-OPC_related|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 5.78e-04 | 192 | 38 | 3 | e6d115143ced6a0d9fe7c98acd3f730bac83f66b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.78e-04 | 192 | 38 | 3 | fee99ca7e658963acf968aa724ef8c96cfc00a5d | |
| ToppCell | 11.5-Airway-Epithelial-Bud_tip_adjacent|Airway / Age, Tissue, Lineage and Cell class | 5.78e-04 | 192 | 38 | 3 | fbb34a959b9bd9cb72a5195a07f4653a957e4ca8 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-Pericytes|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.78e-04 | 192 | 38 | 3 | 7aadc7c5bd03274f9861dde2febda5c37f8afc9c | |
| ToppCell | IPF-Endothelial-VE_Arterial|IPF / Disease state, Lineage and Cell class | 5.87e-04 | 193 | 38 | 3 | bf83b1fe9d38408f30eee4eb634341c04ef82791 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.96e-04 | 194 | 38 | 3 | 8f19e553f18c313c2a2ff9453884b9484b255d71 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.96e-04 | 194 | 38 | 3 | f95935153bd2c4c3c7b2b729da6f7e98b45fed79 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.96e-04 | 194 | 38 | 3 | 67fbb81b7d20cb63be27b2a2beea5b5689f8e08c | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.14e-04 | 196 | 38 | 3 | 429de4119c8b2193c992d36a6af84f806730cbee | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium_(RGS5+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.14e-04 | 196 | 38 | 3 | 8c8a73d9d9581b8d9a9babfa93459d12fb9eb3ac | |
| ToppCell | medial-Endothelial-Capillary_Intermediate_2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.14e-04 | 196 | 38 | 3 | 07e6214e771c65574f0ada65e75f4bda265aa47f | |
| ToppCell | medial-2-Endothelial-Capillary_Intermediate_2|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.14e-04 | 196 | 38 | 3 | d074c24fecd0e3ffca4699fb1a9d443e6d9a858d | |
| ToppCell | medial-Endothelial-Capillary_Intermediate_2-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.14e-04 | 196 | 38 | 3 | 5cc14a5797884ff3a007683048e690a0d7172fc4 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.32e-04 | 198 | 38 | 3 | 1f956e369e00d37835095a001db4b62a79014532 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.32e-04 | 198 | 38 | 3 | dc6fbad0ecdd057189f71afcdb6aca25207314a3 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.41e-04 | 199 | 38 | 3 | 9a08c25bb4851ad4ac9db8916422280f71378c2c | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.41e-04 | 199 | 38 | 3 | 2ed10c5e15c9d5ed0a8bea580842348d5698a07b | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.51e-04 | 200 | 38 | 3 | 3c898e81444b001835c3f1bbc68183078701b135 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-OPC_related-Oligodendrocyte/OPC|2m / Sample Type, Dataset, Time_group, and Cell type. | 6.51e-04 | 200 | 38 | 3 | 3c9a2f02294a9fb892b89e856291bd6423ffa0a9 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2-TYR|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.51e-04 | 200 | 38 | 3 | bfdafb024a7b20d46837b2e6480dd4929253cd62 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-OPC_related|2m / Sample Type, Dataset, Time_group, and Cell type. | 6.51e-04 | 200 | 38 | 3 | 8e49e7e9b02d8411e4ffae1f5113a2c18f5bf179 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2-TYR-L2-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.51e-04 | 200 | 38 | 3 | 04954fbe1e2264077228bb582c9a5897a70e6da2 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2-SERPINF1-L2-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.51e-04 | 200 | 38 | 3 | f922f9f223cbfed71b8e3115b16b51dc4d7b66b8 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.51e-04 | 200 | 38 | 3 | 3eca8ffeb41b664fbdbbd70b375c5d953503ab29 | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.51e-04 | 200 | 38 | 3 | 29054cf55e88e1ac81a562d8dd9af9b7c749321d | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.51e-04 | 200 | 38 | 3 | 7e51715525fdb001b7042b2bfcb9de81ecb5e4ee | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-OPRM1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.51e-04 | 200 | 38 | 3 | 559cf4001a3f985c8357f0102b34fab2e34d2a04 | |
| ToppCell | Neuronal-Inhibitory-iA|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.51e-04 | 200 | 38 | 3 | 5ef4a3dc18a44292184a59ced916183c0699b01e | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2-SERPINF1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.51e-04 | 200 | 38 | 3 | c4e08cf539c12bb7c61be6d44b4f074bb460f526 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-OPRM1-L1-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.51e-04 | 200 | 38 | 3 | cc0d639d38eb99414ba8b54d3000701962394465 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.51e-04 | 200 | 38 | 3 | 913487e065dd580c9cbcbb3c3fc76a8d446f8856 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.51e-04 | 200 | 38 | 3 | 75649534a98bc738fca62d071de0978dc61eb24f | |
| ToppCell | Club-club-9|World / Class top | 6.72e-04 | 45 | 38 | 2 | 646051d8b22c9d35170e8cbecf385b659d8bc676 | |
| Disease | infection | 5.78e-05 | 9 | 38 | 2 | EFO_0000544 | |
| Disease | Dyschondroplasias | 2.72e-04 | 19 | 38 | 2 | C0013366 | |
| Disease | cholesteryl esters to total lipids in large LDL percentage | 7.33e-04 | 31 | 38 | 2 | EFO_0022249 | |
| Disease | response to simvastatin, total cholesterol change measurement, response to fenofibrate | 1.98e-03 | 51 | 38 | 2 | EFO_0007806, GO_1901557, GO_1903491 | |
| Disease | phospholipids in medium VLDL measurement | 2.06e-03 | 52 | 38 | 2 | EFO_0022154 | |
| Disease | total lipids in medium VLDL | 2.22e-03 | 54 | 38 | 2 | EFO_0022153 | |
| Disease | total blood protein measurement | 2.59e-03 | 449 | 38 | 4 | EFO_0004536 | |
| Disease | phospholipids in VLDL measurement | 2.64e-03 | 59 | 38 | 2 | EFO_0022301 | |
| Disease | phospholipids in small VLDL measurement | 2.73e-03 | 60 | 38 | 2 | EFO_0022146 | |
| Disease | free cholesterol in VLDL measurement | 2.82e-03 | 61 | 38 | 2 | EFO_0022276 | |
| Disease | cholesterol in large VLDL measurement | 3.19e-03 | 65 | 38 | 2 | EFO_0021902 | |
| Disease | total lipids in small VLDL | 3.39e-03 | 67 | 38 | 2 | EFO_0022148 | |
| Disease | triglycerides in very small VLDL measurement | 3.49e-03 | 68 | 38 | 2 | EFO_0022144 | |
| Disease | intraocular pressure measurement | 4.06e-03 | 509 | 38 | 4 | EFO_0004695 | |
| Disease | serum alanine aminotransferase measurement | 4.91e-03 | 869 | 38 | 5 | EFO_0004735 | |
| Disease | complex trait | 5.10e-03 | 271 | 38 | 3 | EFO_0010578 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LPCKENPGPSYARRR | 36 | Q9H568 | |
| VVPRDCPRYDPRFVG | 621 | Q8N3Y3 | |
| GSPGEDPRRTEPRYC | 696 | A5PL33 | |
| DGRSATREPPYRVPR | 161 | P43243 | |
| YPESPVCEGRRNRCP | 261 | P05160 | |
| LGEEVRRSYCPARPG | 586 | Q96MM6 | |
| LTEDGRPCRFPFRYG | 101 | Q04756 | |
| GRPRPDFFYRCFPDG | 106 | Q5VZY2 | |
| SYCCYRSRRAPARPP | 626 | Q8TE96 | |
| RSRVPRIDPYGFERP | 6 | Q5TC63 | |
| RPRRCRVFNPYTEFP | 71 | Q9BUP0 | |
| GDLPRPPLRNEFRYF | 21 | Q86XF0 | |
| GAEPCSRPRRPAVYT | 221 | Q9UKQ9 | |
| RPSEGFPNYCTPPRR | 286 | Q5T749 | |
| PEPPERRGRCQRYLL | 81 | O75751 | |
| RRRGEPPREYALPFG | 1381 | Q96JN8 | |
| DGSVRYPISRPRRRC | 311 | P10915 | |
| YPISRPRRRCSPTEA | 316 | P10915 | |
| RPGPYDRPGTARRYI | 206 | P52597 | |
| QPPSRGAAYRRACPR | 31 | Q5VT97 | |
| QYSPRRRPGDPVCPF | 391 | Q07890 | |
| RGYRLPRPAACPAEV | 441 | Q9H3Y6 | |
| RPSGPDFRCIPDRYR | 126 | Q9BQB4 | |
| PRRDPYLGPRDEGYS | 201 | O75526 | |
| AEGACPYPRGSERRP | 1541 | Q9H2D6 | |
| CYPQDLPRPLRSREF | 231 | O43734 | |
| YPRGPREFRGGCRAP | 191 | Q96EI5 | |
| PPFFYRRRFVRGPRP | 226 | Q9Y2T7 | |
| ERPYPCAECGRRFRL | 256 | Q7L3S4 | |
| DAPAYRTPPSRQGRR | 41 | Q5JTV8 | |
| EAPTGSRYRGRPCLP | 96 | Q03431 | |
| ASPVPYRRPRFLRGS | 26 | Q96MI6 | |
| VGRPRPDFFYRCFPD | 111 | Q8NEB5 | |
| ERPYPCPECGRRFSQ | 471 | Q96BV0 | |
| DEEPPYRGPFCGRAR | 546 | O94885 | |
| PFYPRGPREFRGGCR | 201 | Q9H3H9 | |
| KPYPCPDCGRAFRRS | 371 | Q96CS4 | |
| GPSFPARRYGAPRRL | 26 | Q5PR19 | |
| SPYRIRNPFRGSPKC | 541 | Q14966 | |
| KPYPCPDCGRRFRQR | 226 | A8K8V0 |